Institutions Holding Call Options on Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the call option holders of Terns Pharmaceuticals, Inc. (TERN). We have compiled data on the institutions that hold call options on the stock, with a total of 580,000 call options outstanding, which have been reported (via 13F filing form) to have a value of $3.51 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
249,100
calls
|
$1.46 Million
0.0% of portfolio
|
N/A
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
129,400
calls
|
$758,284
0.0% of portfolio
|
N/A
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
96,000
calls
|
$562,560
0.0% of portfolio
|
N/A
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
50,000
calls
|
$293,000
0.0% of portfolio
|
Q2 2024
Added 206.75%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
34,400
calls
|
$201,584
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Gts Securities LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
11,100
calls
|
$65,046
0.0% of portfolio
|
N/A
|
|
|
Myda Advisors LLC
Inwood, NY |
Nov 13, 2024 Q3 2024 |
10,000
calls
|
$58,600
0.02% of portfolio
|
Q3 2024
Reduced 75.0%
|